Menu +

Tag: covi19

Roche initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia

Posted on | By pharma

Roche is also close to completing enrolment of a global randomised, double-blind, placebo-controlled phase III clinical trial of Actemra®/RoActemra® (tocilizumab) in hospitalised patients with severe COVID-19 pneumonia (COVACTA), with results expected this summer. Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA) to evaluate […]

Read More »

COVID-19 requires gender-equal responses to save economies

Posted on | By pharma

The impact of the COVID-19 pandemic is not gender neutral, as it affects men and women differently. Therefore, we must not be gender blind in our responses to the pandemic, or else women will carry a disproportionately higher economic cost than men. Globally, women are more vulnerable to economic shocks wrought by crises such as […]

Read More »